Kulke MH - Search Results

1

A prospective phase II study of 2-methoxyestradiol administered in combination with bevacizumab in patients with metastatic carcinoid tumors.

Kulke MH, Chan JA, Meyerhardt JA, Zhu AX, Abrams TA, Blaszkowsky LS, Regan E, Sidor C, Fuchs CS. Kulke MH, et al. Cancer Chemother Pharmacol. 2011 Aug;68(2):293-300. doi: 10.1007/s00280-010-1478-7. Epub 2010 Oct 20. Cancer Chemother Pharmacol. 2011. PMID: 20960192 Free PMC article. Clinical Trial.

2

Carcinoid tumors.

Kulke MH, Mayer RJ. Kulke MH, et al. N Engl J Med. 1999 Mar 18;340(11):858-68. doi: 10.1056/NEJM199903183401107. N Engl J Med. 1999. PMID: 10080850 Review. No abstract available.

3

A Phase II study of gemcitabine and docetaxel in patients with metastatic pancreatic carcinoma.

Ryan DP, Kulke MH, Fuchs CS, Grossbard ML, Grossman SR, Morgan JA, Earle CC, Shivdasani R, Kim H, Mayer RJ, Clark JW. Ryan DP, et al. Among authors: kulke mh. Cancer. 2002 Jan 1;94(1):97-103. doi: 10.1002/cncr.10202. Cancer. 2002. PMID: 11815964 Free article. Clinical Trial.

4

A phase II study of troglitazone, an activator of the PPARgamma receptor, in patients with chemotherapy-resistant metastatic colorectal cancer.

Kulke MH, Demetri GD, Sharpless NE, Ryan DP, Shivdasani R, Clark JS, Spiegelman BM, Kim H, Mayer RJ, Fuchs CS. Kulke MH, et al. Cancer J. 2002 Sep-Oct;8(5):395-9. doi: 10.1097/00130404-200209000-00010. Cancer J. 2002. PMID: 12416897 Clinical Trial.

5

A phase II study of modified deGramont 5-fluorouracil, leucovorin, and oxaliplatin in previously treated patients with metastatic colorectal cancer.

Ryan DP, Clark JW, Kulke MH, Fuchs CS, Earle CC, Enzinger PC, Stuart K, Catarius KJ, Winkelmann J, Mayer RJ. Ryan DP, et al. Among authors: kulke mh. Cancer Invest. 2003;21(4):505-11. doi: 10.1081/cnv-120022359. Cancer Invest. 2003. PMID: 14533439 Clinical Trial.

6

Advanced pancreatic cancer: is there a role for combination therapy?

Kulke MH. Kulke MH. Expert Rev Anticancer Ther. 2003 Oct;3(5):729-39. doi: 10.1586/14737140.3.5.729. Expert Rev Anticancer Ther. 2003. PMID: 14599095 Review.

7

A Phase II trial of gemcitabine for metastatic neuroendocrine tumors.

Kulke MH, Kim H, Clark JW, Enzinger PC, Lynch TJ, Morgan JA, Vincitore M, Michelini A, Fuchs CS. Kulke MH, et al. Cancer. 2004 Sep 1;101(5):934-9. doi: 10.1002/cncr.20466. Cancer. 2004. PMID: 15329900 Free article. Clinical Trial.

8

A phase II study of docetaxel in patients with metastatic carcinoid tumors.

Kulke MH, Kim H, Stuart K, Clark JW, Ryan DP, Vincitore M, Mayer RJ, Fuchs CS. Kulke MH, et al. Cancer Invest. 2004;22(3):353-9. doi: 10.1081/cnv-200029058. Cancer Invest. 2004. PMID: 15493355 Clinical Trial.

9

Lack of efficacy of streptozocin and doxorubicin in patients with advanced pancreatic endocrine tumors.

McCollum AD, Kulke MH, Ryan DP, Clark JW, Shulman LN, Mayer RJ, Bartel S, Fuchs CS. McCollum AD, et al. Among authors: kulke mh. Am J Clin Oncol. 2004 Oct;27(5):485-8. doi: 10.1097/01.coc.0000135343.06038.eb. Am J Clin Oncol. 2004. PMID: 15596916

10

A phase II study of epirubicin and thalidomide in unresectable or metastatic hepatocellular carcinoma.

Zhu AX, Fuchs CS, Clark JW, Muzikansky A, Taylor K, Sheehan S, Tam K, Yung E, Kulke MH, Ryan DP. Zhu AX, et al. Among authors: kulke mh. Oncologist. 2005 Jun-Jul;10(6):392-8. doi: 10.1634/theoncologist.10-6-392. Oncologist. 2005. PMID: 15967833 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

235 results

Search Page

Filters